濮阳东方男科看病贵不贵濮阳东方医院看妇科病口碑好不好,濮阳东方男科线上咨询挂号,濮阳东方医院技术很权威,濮阳东方医院看妇科评价好收费低,濮阳东方医院评价比较高,濮阳东方男科非常可靠,濮阳东方医院治早泄怎么收费

VIENNA, April 12 (Xinhua) -- A protein group has been identified as an "allergy multiplier" that causes food allergy, a symptom that could also accompany other allergies and produce serious consequences, Austrian researchers said Tuesday.The so-called non-specific lipid transfer proteins (nsLTP) are believed to be the causes of food allergy, a research team from the Medical University of Vienna said in a new report.These plant allergens are found not only in many fruits and vegetables, but also in cereals and some types of pollen. Due to their compact structures, they are not degraded in the gastrointestinal tract and can trigger immune reactions that cause severe allergic symptoms, said the report.The researchers believe that with nsLTP identified as an " allergy multiplier," diagnostic and treatment procedures could be adapted and improved.

LOS ANGELES, April 1 (Xinhua) -- A NASA Gulfstream-III aircraft equipped with a synthetic aperture radar is scheduled to depart Sunday, April 3 on a nine-day mission to image Hawaii volcanoes, the Jet Propulsion Laboratory (JPL) announced on Friday.The aircraft will fly from the Dryden Aircraft Operations Facility in Palmdale, California to the Big Island of Hawaii to study the Kilauea volcano that recently erupted, said JPL in Pasadena, Los Angeles.The mission will help scientists better understand processes occurring under Earth's surface, JPL said.Developed by JPL, the Uninhabited Aerial Vehicle Synthetic Aperture Radar, or UAVSAR, uses a technique called interferometric synthetic aperture radar that sends pulses of microwave energy from the aircraft to the ground to detect and measure very subtle deformations in Earth's surface, such as those caused by earthquakes, volcanoes, landslides and glacier movements.As the Gulfstream-III flies at an altitude of about 12,500 meters, the radar, located in a pod under the aircraft's belly, will collect data over Kilauea, according to JPL.The UAVSAR's first data acquisitions over this volcanic region took place in January 2010, when the radar flew over the volcano daily for a week. The UAVSAR detected deflation of Kilauea's caldera over one day, part of a series of deflation-inflation events observed at Kilauea as magma is pumped into the volcano's east rift zone.This month's flights will repeat the 2010 flight paths to an accuracy of within 5 meters, or about 16.5 feet, assisted by a Platform Precision Autopilot designed by engineers at NASA's Dryden Flight Research Center on Edwards Air Force Base, California, JPL said.By comparing these camera-like images, interferograms are formed that reveal changes in Earth's surface, said JPL.Between March 5 and 11, 2011, a spectacular fissure eruption occurred along the east rift zone. Satellite radar imagery captured the progression of this volcanic event."The April 2011 UAVSAR flights will capture the March 2011 fissure eruption surface displacements at high resolution and from multiple viewing directions, giving us an improved resolution of the magma injected into the east rift zone that caused the eruption," said JPL research scientist Paul Lundgren."Our goal is to be able to deploy the UAVSAR on short notice to better understand and aid in responding to hazards from Kilauea and other volcanoes in the Pacific region covered by this study," Lundgren added.

CANBERRA, May 26 (Xinhua) -- Australian Health Minister Nicola Roxon on Thursday night said she will not be frightened off by the tobacco industry's attempt to lobby Malaysia to oppose the Australian government's proposal for plain packaging of cigarettes.According to ABC News, big tobacco companies have appointed a former United States ambassador to the World Trade Organization ( WTO), Peter Allgeier, to help them fight the Australian federal government's plain packaging plan, which is due to come into effect this year.An email sent to a Malaysian official and obtained by ABC News showed that Allgeier had a meeting with Malaysia's trade minister before, and he has been lobbying a Malaysian administrator to put pressure on Australia over plain packaging.Allgeier's email also stated that "members of the U.S. congress also have written to the Australian Government outlining concerns about the implications of plain packaging for the integrity of Australia's trade commitments."However, Roxon, who said she has not been approached by Malaysia on the issue, said Allgeier's appointment demonstrated just how far big tobacco is prepared to take its fight."But we won't be frightened off because big tobacco is hiring lobbyists or looking at ways to influence the action we're taking, " she told ABC television on Thursday night.The tobacco industry has already spent millions fighting plain packaging, and last year gave 5.2 million U.S. dollars to the Alliance of Australian Retailers (AAR) to fund an advertising campaign against the plan.If the cigarettes law is enforced, Australia will become the first country in the world to ban logos and brand names from cigarette packaging. Health warnings and the kind of graphic pictures will make up the majority of the packaging, while the rest of the packets will be plain olive green.

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.

BEIJING, Feb. 28 (Xinhua) -- Construction began on China's first low-speed maglev line Monday in Beijing, a project that will make China only the second country with a low-speed maglev line after Japan.The project marked China's ability to industrialize low-speed maglev technologies, said Chang Wensen, father of China's maglev technology and professor at the National University of Defense Technology.The 10-kilometer line runs from Shimenying Station in west Beijing's Mentougou District to Pingguoyuan Station in the Shijingshan District.The line, a section of Line S1 on the Beijing subway network, is expected to be completed in 2013 with a designed speed of 100 to 120 km per hour.China's research of maglev technologies was started in the 1980s by a team led by Chang Wensen. A 204-meter test line in central China's Hunan Province and a 1.5-km test line in north China's Hebei Province were built jointly by Beijing Maglev Technology Development Co., Ltd. and National University of Defense Technology.The intensity of the magnetic field had been tested as safe, according to a test report of Institute of Electrical Engineering, Chinese Academy of Sciences.The cost of the low-speed maglev line was estimated at 300 million yuan (4.6 million U.S. dollars) per kilometer, slightly more than light rail, but cheaper than the subway, which cost more than 600 million yuan a kilometer, said Li Jie, director of technology research center of National University of Defense Technology.The technology was also under consideration for Line 8 of the subway network in Shenzhen, in south China's Guangdong Province, said Liu Zhiming, board chairman of Beijing Maglev Technology Development Co., Ltd.."If Shenzhen adopts the technology, Line 8 will be China's second low-speed maglev line," he said.The world's first low-speed maglev line, at 8.9 km long, was completed in Japan in March 2005.Maglev, short for magnetic levitation, technology uses a large number of magnets to lift and propel a vehicle, making it faster, quieter and smoother than conventional wheeled transport systems.High-speed maglev vehicles can reach speeds of 450 km per hour and are usually used in long distance transportation, while low-speed maglev lines are usually used in short distance transportation.Construction also began on another seven lines on the Beijing subway network Monday.With an investment of 82 billion yuan (12 billion U.S. dollars), the eight lines will total 113.7 km in length and are expected to open from 2013 to 2015.Beijing has 16 lines under construction.